Data Integrity, Lab Control Issues Lead to 483s for Two Manufacturers By Sam | February 12, 2017 The FDA issued Form 483s to two drug manufacturers for data integrity and laboratory issues. Source: Drug GMP Report Posted in Drug GMP Report